The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data.

Researchers from low and middle-income countries who work in neglected tropical diseases (NTDs) are invited to apply for a fellowship starting this autumn.

12 March 2020, Bangkok (Thailand) – Adding a third antimalarial drug to current artemisinin-combination therapies (ACTs) provides effective treatment against multidrug-resistant falciparum malaria in Southeast Asia, say Mahidol and Oxford University researchers in a study published today in The Lanc...

Simon Croft, Professor of Parasitology at the London School of Hygiene and Tropical Medicine, has been involved in visceral leishmaniasis research for 38 years. Prof Croft has been instrumental in setting up the IDDO’s visceral leishmaniasis data platform, including serving as the Chair of its Scien...

Il est désormais possible de déposer des demandes d'accès aux données sur la plate-forme de données Ebola. La plate-forme détient actuellement, sous l'autorité des gouvernements, ministères et organisations des pays touchés par le virus Ebola, des données concernant plus de 13 500 patients. Et ce no...

The Ebola Data Platform is now open for data access applications. The platform currently holds contributed data from >13,500 patients under the authority of governments, ministries, and organisations in Ebola-affected countries, and this number is increasing. Researchers can apply to access the d...

A statistical analysis of data hosted within the WWARN repository from 4,214 participants across multiple study sites in Africa has been published in BMC Medicine. Results indicate that the local prevalence of resistance-associated markers should be considered when choosing a first-line drug to ensu...

Today is the International Day of Women and Girls in Science. This day recognises and celebrates the critical role played by women but also aims to promote their full and equal access to participation in science. However, despite more women than ever working across the sciences, it is still a male-d...

Early-career researchers and global health professionals can apply for grants to undertake work in the field of tropical medicine.

A new initiative to tackle the problem of substandard and falsified (SF) medical products in Africa has been adopted by seven countries on the continent. The Lomé Initiative, launched in Lomé, the capital of Togo, by heads of state from the Republic of the Congo, Niger, Senegal, Togo, Uganda, Ghana,...

Governments, funders, and research bodies must take action to ensure that research is undertaken ethically during global health emergencies, says a new report from the Nuffield Council on Bioethics.

When we are ill, we expect our medicines to work as intended. But what if they do not contain the ingredients listed on the packaging? The Pharmacide Arts exhibition “What’s in your medicines?” showcases the original artwork of 11 South East Asian artists.

IDDO has just launched its first newsletter to update our scientific communities across our growing, data re-use collaborations. Sign-up to receive it.

This year we mark a decade of WWARN. As a unique collaborative data-sharing framework, over the last ten years WWARN has proved it is possible to produce policy-changing scientific evidence about the treatment of malaria from the collection, curation and further analysis of existing data.

Art exhibition “What’s in your medicines?” (Pharmacide Arts) is coming to the University of Health Sciences in Vientiane from 17–25 December 2019.

Sulaiman Jalloh, médecin en Sierra Leone, a récemment rejoint IDDO pour effectuer un stage de recherche. Dans cet entretien, il nous parle de sa carrière, de son vécu au cours de l’épidémie d’Ebola 2014-16 et nous fait part de ses réflexions sur la façon dont la recherche future devrait être prioris...

Sulaiman Jalloh, a medical doctor from Sierra Leone, has recently joined IDDO for a research internship. Here, he talks about his career to date, his experiences during the 2014–16 Ebola outbreak and reflections about how future research should be prioritised.

WWARN’s Clinical Scientific Group have published new research in BMC Medical Research Methodology, dealing with indeterminate outcomes in antimalarial drug efficacy trials: A comparison between complete case analysis, multiple imputation and inverse probability weighting.

WWARN’s Professor Joel Tarning has received a Bailey K. Ashford Medal today at ASTMH. The medal is named in honour of Bailey K. Ashford for recognising the connection between hookworm infection and anaemia at the age of 26. 

Join us at the symposia on Poor Quality Drugs and Antimicrobial Resistance at this year’s ASTMH. Chaired by Dr Joel Breman, ASTMH President-elect, the #98 symposia takes place on Friday 22 November, in Potomac C (Ballroom Level) from 4pm to 5.45pm.